您當前所在的位置:首頁>>獸醫科技進展

重組禽流感病毒二價滅活疫苗(H5N1 Re-8株和H7N9 H7-Re1株)對雉免疫效果的研究

點擊數:7456  時間:2019-08-13 16:50:11  來源: 信息處      

為評估重組禽流感病毒二價滅活疫苗(H5N1 Re-8株和H7N9 H7-Re1株)對雉的免疫保護效果,選取30日齡的雉,按照免疫程序首免後21 d,加強免疫1次,分别于接種前和接種後定期采血,分離血清,檢測H5、H7亞型HI抗體滴度。結果顯示,免疫前,雉血清中H5、H7亞型HI抗體滴度均為0;免疫後 14 d,H5和H7亞型抗體平均滴度分别達到7.0log2和7.07log2,49 d後平均滴度達到峰值,分别為8.04log2和9.20log2;H5亞型免疫有效期可達105 d以上,H7亞型可達189 d以上。結果表明,重組禽流感病毒二價滅活疫苗(H5N1 Re-8株+H7N9 H7-Re1株)對雉具有良好的免疫保護效果且安全性良好,但疫苗免疫49 d後,H5、H7抗體效價逐漸下降,133 d後明顯下降,群體免疫合格率低于70%,因此生産中推薦,30日齡首免後,51日齡和5月齡各加強免疫1次。本研究為珍稀禽的禽流感免疫疫苗選擇和程序制定提供了參考。

Study on the Immune Effects of Recombinant Avian Influenza VirusBivalent Inactivated Vaccines(H5N1 Re-8+H7N9 H7-Re1 Strain)in Pheasants

In order to evaluate theimmune effects of recombinant avian influenza virus(A/V) bivalentinactivated vaccines(H5N1 Re-8+H7N9 H7-Re1 strain)in pheasants,30-day-old pheasants wereselected for first vaccination,followed by boostervaccination after 21 days according to immune procedures,and their blood samples were collected regularly before and aftervaccination respectively to test the titers of HI antibodies against H5 and H7subtype AIV. The results showed that,before vaccination,the titers of HI antibodies against H5 and H7 subtypes in the serumof pheasants were 0;and the average titers of H5 and H7subtypes could reach to 7.0log2 and 7.07log2 respectively after 14 days,then increased to the peak after 49 days,whichwere 8.04log2 and 9.20log2 respectively;the immunevalidity for H5 subtype AIV could remain for 105 days or above,and that for H7 subtype could be up to 189 days,which indicated the immune effects and security of bivalentinactivated vaccines were good. However,the titers ofH5 and H7 antibodies decreased gradually after 49 days of vaccination,then decreased significantly after 133 days,andthe qualified rates at herd level was less than 70%. Therefore,it was suggested that,after the firstimmunization at the age of 30 days,the reinforcedvaccination should be carried out at the ages of 51 days and 5 monthsrespectively. In conclusion,the research would providesome references for selecting vaccines(for rare andprecious birds)and developing relevant procedures.


全文下載鍊接:http://kns.cnki.net/KCMS/detail/37.1246.S.20190802.1405.034.html



網站首頁 | 網站聲明 | 聯系我們 | 網站幫助 |

版權所有及制作維護:中國動物衛生與流行病學中心

魯ICP備08016398号  公安機關備案号 37020302370412

網站保留所有權,未經許可不得複制、鏡像